JP2009055882A - キトサン配合飲料 - Google Patents
キトサン配合飲料 Download PDFInfo
- Publication number
- JP2009055882A JP2009055882A JP2007228408A JP2007228408A JP2009055882A JP 2009055882 A JP2009055882 A JP 2009055882A JP 2007228408 A JP2007228408 A JP 2007228408A JP 2007228408 A JP2007228408 A JP 2007228408A JP 2009055882 A JP2009055882 A JP 2009055882A
- Authority
- JP
- Japan
- Prior art keywords
- chitosan
- water
- chondroitin sulfate
- beverage
- astringency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 27
- 229920001661 Chitosan Polymers 0.000 claims abstract description 85
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229920001287 Chondroitin sulfate Polymers 0.000 claims abstract description 21
- 229940059329 chondroitin sulfate Drugs 0.000 claims abstract description 20
- 150000003839 salts Chemical class 0.000 claims abstract description 8
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims description 6
- 235000019658 bitter taste Nutrition 0.000 abstract description 2
- 235000019606 astringent taste Nutrition 0.000 description 23
- 230000000052 comparative effect Effects 0.000 description 13
- 239000000243 solution Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 230000001953 sensory effect Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000012085 test solution Substances 0.000 description 6
- 239000008213 purified water Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 241000238557 Decapoda Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 241000238366 Cephalopoda Species 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 241000251730 Chondrichthyes Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- -1 hydrochloric acid Chemical class 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 241000254032 Acrididae Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000239366 Euphausiacea Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 description 1
- MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical class O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 229940094517 chondroitin 4-sulfate Drugs 0.000 description 1
- 229940006423 chondroitin sulfate sodium Drugs 0.000 description 1
- 229940107200 chondroitin sulfates Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000000850 deacetylating effect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 150000002302 glucosamines Chemical class 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000002997 ophthalmic solution Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
Landscapes
- Non-Alcoholic Beverages (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
【解決手段】キトサン、及びコンドロイチン硫酸又はその塩を配合することを特徴とする飲料。
【選択図】なし
Description
そこで、キトサン及び水溶性キトサンを含む製品の風味改善方法として、ゼインのマトリックスでキトサン及び水溶性キトサンを固定化する方法(特許文献3参照)、アルギン酸塩を配合する方法(特許文献4参照)等が報告されているが、前者は固形物であり、後者は溶液の粘度が非常に高くなるため飲料を提供する際には適さない。
[試験液調製]
各試験液の処方は表1〜4に示す。
[官能試験方法(渋味の評価)]
沈殿が無く、飲料としての粘性に問題が無いと判断した試験液の渋味について、成人男女計5名からなるパネラーによる官能評価を行った。
[結果]
(1)コンドロイチン硫酸の効果(pH4.5)
水溶性キトサンとコンドロイチン硫酸ナトリウム(生化学工業(株))を配合し、pHを4.5に調整した処方を実施例1とした。実施例1からコンドロイチン硫酸ナトリウムを抜いた処方を比較例1、コンドロイチン硫酸ナトリウムの代わりに同じ多糖類であるデキストリン(和光純薬(株))、アルギン酸ナトリウム(和光純薬(株))、ペクチン(和光純薬(株))、λ-カラギーナン(和光純薬(株))、を配合した処方を比較例2〜5とした。実施例1及び比較例1の水溶性キトサンをキトサンに置き換えたものを実施例5及び比較例9とした。各処方と、各試験液調製直後の目視による沈殿の有無及び飲料としての粘性の適否、並びに官能試験の結果を表1に記載した。
(2)水溶性キトサンの渋味に対するコンドロイチン硫酸とpHの影響
実施例1のpHを2.5及び6.5に調整したものを各々実施例2及び3とし、実施例2及び3からコンドロイチン硫酸ナトリウムを抜いた処方を各々比較例6及び7とした。
(3)キトサンの渋味に対するコンドロイチン硫酸とpHの影響
表2における実施例1〜3並びに比較例1、6及び7の水溶性キトサンを、キトサンに置き換えたものを実施例4〜6及び比較例8〜10とした。
(4)水溶性キトサンの渋味に対するコンドロイチン硫酸配合量の影響
実施例1から水溶性キトサンとコンドロイチン硫酸ナトリウムの配合比を変化させたものを実施例7〜11及び比較例11とした。
Claims (4)
- キトサン、及びコンドロイチン硫酸又はその塩を配合することを特徴とする飲料。
- pHが2.0〜7.0である請求項1記載の飲料。
- キトサンが、水溶性キトサンである請求項1記載の飲料。
- 水溶性キトサンが、キトサンオリゴ糖である請求項3記載の飲料。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007228408A JP4840298B2 (ja) | 2007-09-04 | 2007-09-04 | キトサン配合飲料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007228408A JP4840298B2 (ja) | 2007-09-04 | 2007-09-04 | キトサン配合飲料 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009055882A true JP2009055882A (ja) | 2009-03-19 |
JP4840298B2 JP4840298B2 (ja) | 2011-12-21 |
Family
ID=40552215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007228408A Active JP4840298B2 (ja) | 2007-09-04 | 2007-09-04 | キトサン配合飲料 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4840298B2 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014195437A (ja) * | 2013-03-29 | 2014-10-16 | 地方独立行政法人鳥取県産業技術センター | 加熱用復渋抑制柿ピューレ |
CN108157971A (zh) * | 2018-02-08 | 2018-06-15 | 沈勇子 | 一种壳寡糖液体口服制剂及其制备方法 |
WO2019130724A1 (ja) | 2017-12-27 | 2019-07-04 | サントリーホールディングス株式会社 | キトサンを含有する非発酵茶飲料または半発酵茶飲料 |
WO2020100405A1 (ja) | 2018-11-14 | 2020-05-22 | サントリーホールディングス株式会社 | キトサンを含有する飲料 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11228450A (ja) * | 1997-03-28 | 1999-08-24 | Eisai Co Ltd | 苦味等を隠蔽した経口薬剤 |
JP2002003379A (ja) * | 2000-06-23 | 2002-01-09 | Taisho Pharmaceut Co Ltd | ビタミンb1誘導体配合組成物 |
JP2002539233A (ja) * | 1999-03-22 | 2002-11-19 | ヴィルバク | リウマチ障害を一般投与によって予防または治療するための、コンドロイチン硫酸およびキトサンに基づく組成物 |
JP2004305090A (ja) * | 2003-04-07 | 2004-11-04 | Mitsui Norin Co Ltd | 茶飲料の混濁防止方法 |
JP2006191830A (ja) * | 2005-01-12 | 2006-07-27 | Unitika Ltd | 脂肪の蓄積を抑制する食品 |
-
2007
- 2007-09-04 JP JP2007228408A patent/JP4840298B2/ja active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11228450A (ja) * | 1997-03-28 | 1999-08-24 | Eisai Co Ltd | 苦味等を隠蔽した経口薬剤 |
JP2002539233A (ja) * | 1999-03-22 | 2002-11-19 | ヴィルバク | リウマチ障害を一般投与によって予防または治療するための、コンドロイチン硫酸およびキトサンに基づく組成物 |
JP2002003379A (ja) * | 2000-06-23 | 2002-01-09 | Taisho Pharmaceut Co Ltd | ビタミンb1誘導体配合組成物 |
JP2004305090A (ja) * | 2003-04-07 | 2004-11-04 | Mitsui Norin Co Ltd | 茶飲料の混濁防止方法 |
JP2006191830A (ja) * | 2005-01-12 | 2006-07-27 | Unitika Ltd | 脂肪の蓄積を抑制する食品 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014195437A (ja) * | 2013-03-29 | 2014-10-16 | 地方独立行政法人鳥取県産業技術センター | 加熱用復渋抑制柿ピューレ |
WO2019130724A1 (ja) | 2017-12-27 | 2019-07-04 | サントリーホールディングス株式会社 | キトサンを含有する非発酵茶飲料または半発酵茶飲料 |
JP2019115325A (ja) * | 2017-12-27 | 2019-07-18 | サントリーホールディングス株式会社 | キトサンを含有する非発酵茶飲料または半発酵茶飲料 |
AU2018398427B2 (en) * | 2017-12-27 | 2021-10-28 | Suntory Holdings Limited | Chitosan-containing non-fermented tea beverage or semi-fermented tea beverage |
CN108157971A (zh) * | 2018-02-08 | 2018-06-15 | 沈勇子 | 一种壳寡糖液体口服制剂及其制备方法 |
WO2020100405A1 (ja) | 2018-11-14 | 2020-05-22 | サントリーホールディングス株式会社 | キトサンを含有する飲料 |
Also Published As
Publication number | Publication date |
---|---|
JP4840298B2 (ja) | 2011-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4248653B2 (ja) | 易嚥下補助組成物並びにこれを用いた食品用組成物及び医薬品用組成物 | |
JP5184257B2 (ja) | 卵殻膜粉末を含有する飲料 | |
JP4652486B2 (ja) | コンドロイチン硫酸を含有する軟骨水系溶媒抽出物とケルセチン配糖体を含有する経口投与用製剤 | |
KR20090115936A (ko) | 알긴산을 포함한 식이요법 제품 | |
JP6285497B2 (ja) | 鶏冠抽出物含有経口組成物及び鶏冠抽出物の香味に由来する摂取困難性の改善方法 | |
JP4840298B2 (ja) | キトサン配合飲料 | |
JP2004283073A (ja) | 咀嚼・嚥下困難者用食品ならびに咀嚼・嚥下補助組成物 | |
CN110960497B (zh) | 一种透明质酸口含片及其制备方法 | |
JP2004350680A (ja) | 咀嚼・嚥下困難者用食品に適したゲル状組成物及びゲル化剤組成物 | |
JPH02248401A (ja) | 低分子グアーガム、その製造法およびそれを含有する飲食品 | |
JP4843837B2 (ja) | チアミン誘導体含有組成物 | |
JP2007099653A (ja) | 関節痛改善剤 | |
JP5151083B2 (ja) | 経口用組成物 | |
JP6566581B2 (ja) | 安定性に優れたセラミド含有組成物 | |
JP2002034505A (ja) | シリマリン配合食品組成物 | |
JP6802627B2 (ja) | ロイシンの苦味低減剤及びロイシンの苦味低減方法 | |
JPWO2019155955A1 (ja) | コラーゲンペプチドを含む液状経口用組成物及びコラーゲンペプチドを含む液状経口用組成物の風味改善方法 | |
JP5923896B2 (ja) | ガレート型カテキン含有食品組成物 | |
JP4131770B2 (ja) | 健康食品 | |
KR20200032482A (ko) | 쓴맛의 맛 개선 조성물 | |
JP4992162B2 (ja) | 鉄イオン配合内服液剤 | |
JP5270893B2 (ja) | 異味成分を含有する速崩壊性顆粒の製造方法 | |
JP3944116B2 (ja) | 鉄臭味抑制剤 | |
JP7389529B1 (ja) | 飲料 | |
JP2017163999A (ja) | N−アセチルグルコサミンを含む風味改善方法及び風味改善用組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD07 | Notification of extinguishment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7427 Effective date: 20090624 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100601 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110527 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110531 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110729 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110906 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110919 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4840298 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20141014 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20141014 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |